What is it about?

a very good response related to antiviral drugs against HCV mixed cryoglobulinemia

Featured Image

Read the Original

This page is a summary of: Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience, Infection and Drug Resistance, June 2018, Dove Medical Press,
DOI: 10.2147/idr.s167093.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page